Drugs / Granulocyte colony-stimulating factor (G-CSF)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02390843 Background | Feb 2015 → Sep 2019 | Ewing sarcoma, Wilms tumor, clear cell sarcoma, germ cell tumor +7 | Emory University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Granulocyte colony-stimulating factor (G-CSF) | “Granulocyte colony-stimulating factor (G-CSF)” NCT02390843 ↗ |
| Known as | G-CSF | “Myeloid growth factor (G-CSF or pegylated G-CSF)” NCT02390843 ↗ |